Barricaid Annular Closure Device Treatment in New Jersey

Certain patients facing a heightened risk of recurrent disc herniation may benefit from adding the Barricaid Annular Closure Device during a discectomy procedure. Having achieved FDA approval in the United States following extensive use in Europe, Barricaid has demonstrated effectiveness in reducing the likelihood of re-herniation and disc collapse in select individuals who undergo microdiscectomy.

We invite you to call our Englewood office to discuss whether this approach may be right for your spine condition.

Background texture
older woman smiling

How the Barricaid Device Works

Disc herniations occur when the nucleus (the softer center) pushes through a weak spot or tear in the annulus (the tougher outer layer). While small slit-like defects pose a relatively low risk for future herniations, a larger defect can raise that risk to around 25%. Barricaid addresses this vulnerability by sealing the defect and anchoring to the vertebra, creating a protective barrier that reduces the chance of additional herniation.

Contact us today to learn more about whether adding Barricaid to your microdiscectomy may enhance your surgical outcome.

Barricaid Annular Closure Device

Barricaid Annular Closure Device

Featured Video Barricaid Surgical Technique

Barricaid Annular Closure Device video

Schedule a Consultation

Contact Us

A Look at Barricaid's Background

Barricaid has been in clinical use for over eight years, particularly in Europe, and randomized studies comparing it to standard microdiscectomy have shown a significant decrease in re-herniation rates among appropriate candidates. By reinforcing the integrity of the disc space, this device helps safeguard against the strain placed on the remaining disc material post-surgery.

Background media

Minimizing Recurrent Herniation

Even with careful microdiscectomy, roughly 10–15% of patients may experience a recurring herniation over time. Those with a tall disc height or a larger annular defect are especially at risk. Barricaid mitigates this risk by literally sealing off the defect, blocking potential disc material from escaping again in the future.

surgical light

Surgery and Recovery

Dr. Stieber typically places the Barricaid Annular Closure Device during a microdiscectomy, and the procedure is often performed on an outpatient basis. While most patients see an improvement in symptoms soon after surgery, activity modifications are advised for the initial few weeks to support proper healing. Many individuals can resume sedentary or office work within about a week.

Banner media
Doctor media

Why Choose Dr. Stieber?

A board-certified orthopedic spine surgeon, Dr. Jonathan Stieber has been closely involved in the development and research of this novel technique. He offers the Barricaid option to eligible patients who seek relief from painful, recurrent disc herniations. This commitment to evidence-based advancements helps ensure each patient receives comprehensive, personalized care.


We welcome you to schedule a consultation to determine if the Barricaid Annular Closure Device could strengthen your spine surgery results and help prevent future herniations.

Schedule a Consultation And Get The Pain-Free Lifestyle You Deserve

NYC spine surgery specialist, Dr. Jonathan Stieber, provides his patients with the most effective treatment options available, all of which are tailored to meet your individual needs. With Dr. Stieber guiding your care, it is possible to say goodbye to pain and enjoy an active lifestyle once again.

Contact Us
Contact Us Page
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at (646) 916-3962.
Contact Us